Key result
Asymptomatic patients with zero coronary artery calcium score had a pooled prevalence of non-calcified coronary plaques of 10%.
Why the study?
There is growing interest in understanding the coronary atherosclerotic burden in asymptomatic patients with zero coronary artery calcium score.
Meta-Analysis (n=37,808)
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“I've seen patients that were missed because of [their] calcium score of 0—young patients who do have a heart attack. And once you experience that, you don't want to miss them ever again.”
“There's always been this question that if you don't have coronary calcium you could still have plaque. Calcification happens later in the plaque process so the noncalcified plaque that develops first, what's the true prevalence of that? And how reassured can you be if you have no coronary calcium on a calcium score?”
“Firstly, it is well known that zero CAC does not guarantee zero risk. Higher risk factor burden is linked to relatively higher risk even among asymptomatic subjects with zero CAC. We have shown that even in our original 'power of zero' paper. And therefore, it is not surprising to see such signals in these data. There is always going to be minimal residual risk in a CAC-zero group.”
May signal residual risk despite zero calcium scores; hypothesis-generating for refined stratification beyond CAC scoring.
BACKGROUND There is growing interest in understanding the coronary atherosclerotic burden in asymptomatic patients with zero coronary artery calcium score (CACS). In this population, we aimed to investigate the prevalence and severity of non-calcified coronary plaques (NCP) as detected by coronary CT angiography (CCTA), and to analyze the associated clinical predictors. METHODS This was a systematic review with meta-analysis of studies indexed in PubMed/Medline and Web of Science from inception of the database to March 31st, 2023. Using the random-effects model, separate Forest and Galbraith plots were generated for each effect size assessed. Heterogeneity was assessed using the I2 statistics whilst Funnel plots and Egger's test were used to assess for publication bias. RESULTS From a total of 14 studies comprising 37808 patients, we approximated the pooled summary estimates for the overall prevalence of NCP to be 10% (95%CI: 6%-13%). Similarly, the pooled prevalence of obstructive NCP was estimated at 1.1% (95%CI: 0.7%-1.5%) from a total of 10 studies involving 21531 patients. Hypertension [OR: 1.46 (95%CI:1.31-1.62)] and diabetes mellitus [OR: 1.69 (95%CI: 1.41-1.97)] were significantly associated with developing any NCP, with male gender being the strongest predictor [OR: 3.22 (95%CI: 2.17-4.27)]. CONCLUSION There is a low burden of NCP among asymptomatic subjects with zero CACS. In a subset of this population who have clinical predictors of NCP, the addition of CCTA has a potential to provide a better insight about occult coronary atherosclerosis, however, a risk-benefit approach must be factored in prior to CCTA use given the low prevalence of NCP.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Sama et al. (2023) conducted a meta-analysis in asymptomatic patients with zero coronary artery calcium score (n=37,808). Zero coronary artery calcium score was evaluated on overall prevalence of non-calcified coronary plaques (95% CI 6-13). Asymptomatic patients with zero coronary artery calcium score had a pooled prevalence of non-calcified coronary plaques of 10%.
Synapse has enriched 10 related papers. Consider them for comparative context: